Credit Suisse’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,142
Closed -$138K 3260
2020
Q2
$138K Sell
3,142
-13,718
-81% -$603K ﹤0.01% 3158
2020
Q1
$553K Buy
16,860
+3,380
+25% +$111K ﹤0.01% 2467
2019
Q4
$688K Buy
+13,480
New +$688K ﹤0.01% 2742
2014
Q3
Sell
-55
Closed -$195K 4081
2014
Q2
$195K Buy
55
+24
+77% +$85.1K ﹤0.01% 3951
2014
Q1
$116K Sell
31
-32
-51% -$120K ﹤0.01% 4112
2013
Q4
$205K Buy
63
+37
+142% +$120K ﹤0.01% 3863
2013
Q3
$107K Sell
26
-43
-62% -$177K ﹤0.01% 3661
2013
Q2
$232K Buy
+69
New +$232K ﹤0.01% 3396